MI7.1-5 | Respiratory Tract Infections — Case Study

CLINICAL SCENARIO

A 58-year-old male paan shop owner from Karimnagar, Telangana, presents to the district hospital with a 2-week history of productive cough with rust-coloured sputum, pleuritic right-sided chest pain, and fever (38.9°C). He has type 2 diabetes mellitus (poorly controlled, HbA1c 10.2%) and drinks alcohol socially. On examination: dull percussion and bronchial breathing at the right base. SpO2 90% on room air. CXR: dense homogeneous opacity of the right lower lobe with air bronchograms. Sputum Gram stain: lancet-shaped Gram-positive diplococci in pairs. The treating physician wishes to initiate antibiotic therapy and simultaneously screen for tuberculosis as NTEP protocol, given the risk factors and rural setting.

Section 1: Microbiological Diagnosis of CAP

Identify the most likely causative organism from the Gram stain findings and clinical picture. Describe the specific virulence factors of this organism that explain: (a) the lobar consolidation pattern, (b) the pleuritic pain, and (c) the rust-coloured sputum. What additional laboratory tests (culture, sensitivity, antigen test) would you order, and on which specimen?

Guidance: Focus on how capsular polysaccharide, pneumolysin, and teichoic acid contribute to the pathology. Mention the role of the Optochin sensitivity test and bile solubility for identification. Word target: ~180 words.

Section 2: NTEP TB Screening Ladder for this Patient

This patient has risk factors (diabetes, rural domicile, low socio-economic status) that mandate NTEP TB screening alongside CAP treatment. Outline the NTEP laboratory diagnostic ladder in sequential order: (a) specimen collection criteria for sputum, (b) CBNAAT (Xpert MTB/RIF) as first-line test, (c) FNAC or LPA if CBNAAT is indeterminate, and (d) culture on LJ medium as gold standard. For each step, state the turnaround time and what the result changes in management.

Guidance: Use the current NTEP diagnostic algorithm (2020+). Emphasise that sputum must meet quality criteria (≤10 squamous cells, ≥25 PMNs per LPF). If CBNAAT detects RIF resistance, state the immediate NTEP programmatic action. Word target: ~200 words.

Section 3: Empirical Antibiotic Therapy and Severity Assessment

Calculate the CURB-65 score for this patient, list each component score with justification, and determine the appropriate site of care. Prescribe an empirical antibiotic regimen for CAP, taking into account his diabetes and the likely organism. What dose adjustment (if any) is needed for the antibiotic in the context of diabetes-related CKD? At what clinical milestone would you de-escalate to oral therapy?

Guidance: State each CURB-65 criterion clearly (Confusion, Urea/BUN, RR, BP, Age). The empirical regimen should include a beta-lactam; address the need (or lack thereof) for atypical coverage given the Gram stain findings. Word target: ~150 words.

Section 4: Complications and Infection Control

The patient deteriorates on day 3. A repeat CXR shows a new right pleural effusion. Outline the microbiological criteria that would categorise the effusion as a simple parapneumonic effusion vs. an empyema (Light's criteria, pH, glucose, LDH, culture). If pus is obtained on thoracocentesis, what organisms — in addition to Streptococcus pneumoniae — may be co-pathogens, and what would change in the antibiotic regimen? Additionally, state one infection control measure relevant to droplet transmission in the ward.

Guidance: Light's criteria: protein >0.5 × serum, LDH >0.6 × serum or >200 IU/L, pleural:serum LDH >0.6. Empyema criteria: pH <7.2, glucose <2.2 mmol/L, frank pus. Anaerobes (Fusobacterium, Peptostreptococcus) may be co-pathogens if aspiration occurred. Word target: ~120 words.

PEER REVIEW

Review your peer's assignment using the following criteria:
1. Organism identification (Section 1): Did they correctly identify S. pneumoniae from the Gram stain description? Did they link the virulence factors (capsule, pneumolysin, teichoic acid) to the specific clinical features (consolidation, rust sputum, pleurisy)?
2. NTEP ladder accuracy (Section 2): Is the CBNAAT → LPA → LJ culture sequence correctly stated? Are turnaround times mentioned? Is the management response to RIF resistance correct?
3. CURB-65 logic (Section 3): Is each CURB-65 component scored and explained? Is the recommended site of care consistent with the score? Is the regimen appropriate for the organism and setting?
4. Clinical reasoning quality: Does the response show integrated thinking (microbiology + pharmacology + clinical management) rather than a list of facts?

Provide at least two specific, constructive comments — one highlighting a strength and one identifying an area for improvement. Avoid comments on writing style alone.